Among the total number of deaths caused by different types of cancer, esophageal cancer is the sixth most significant. Several conventional treatments, such as radiotherapy, chemotherapy, and surgery have multiple side effects, including off-target toxicity and multidrug resistance (MDR).
Another strategy for esophageal cancer treatment is chemo-photodynamic therapy, the efficacy of which is limited by its inability to target tumors, lack of suitable microenvironment for photodynamic therapy (PDT), and tendency to cause adverse side effects.
Scientists sought to address these limitations of the existing therapies and developed a novel theranostic nanoplatform, namely, GCDs-Ce6/Pt-EGF, which has been found to be effective against esophageal cancer. This study has been recently published in Biomedicine & Pharmacotherapy.
Conventional Treatments of Esophageal Cancer
The majority of the available treatments for esophageal cancers come with some limitations. For instance, as this type of cancer is prone to metastasis, surgery cannot completely remove the tumor. In the case of radiotherapy, the narrow dose window limits its purpose. Low-dose radionuclides have limited tumor cell killing ability, while high dosage can affect healthy cells as well.
Although chemotherapy, using Cisplatin or Doxorubicin, can effectively eliminate tumor cells with metastasis and has a superior anti-tumor effect, it often severely damages the kidney and liver of the patient. Combinational therapy, such as chemoradiation with surgery, was effective against esophageal cancer, but this therapy showed high in-hospital mortality.
Two of the limitations associated with photothermal therapy and oxidative therapy are the recurrence of tumor cells and damage caused to off-target non-cancerous cells as well. PDT is effective against different types of cancers, such as breast, prostate, liver, and esophagus, with a better biosafety effect. However, its effectiveness is compromised by abundant glutathione (GSH) in the tumor microenvironment and hypoxia.
Nanotechnology-based Cancer Treatments
Nanoparticles are widely used in biomedical research, owing to their nanoscale dimension (1–100 nm) and multiple unique properties. Carbon nanodots are a type of carbon nanoparticle that is applied for fluorescence sensing, bioimaging, and drug delivery. The development of tumor-targeted drug delivery systems is essential to facilitate tumor-specific treatment without adversely affecting the normal cells.
Drugs are often modified to identify tumor cells by recognizing specific receptors expressed in them. In many types of cancers, including esophageal cancer, the epidermal growth factor receptor (EGFR) is found to be overexpressed. Compared to healthy individuals, esophageal cancer patients exhibit a significantly higher expression of EGFR protein in the mucosa. Hence, this receptor has been utilized as a key target for anti-tumor drug delivery.
A Novel Theranostic Nanoplatform for Esophageal Cancer Treatment
Recently, scientists have developed an all-in-one theranostic nanoplatform, known as GCDs-Ce6/Pt-EGF for esophageal cancer treatment. This nanoplatform utilized green fluorescence carbon dots (GCDs), which were synthesized using p-aminosalicylic acid and p-aminobenzamide with a molar ratio of 1:1 at 200℃ for 6 hours, via the hydrothermal method.
GCDs were characterized using atomic force microscopy (AFM) and transmission electron microscopy (TEM), which revealed a uniform dispersion of quasi-sphere GCD nanomaterials of 4.72 nm size. The fluorescence quantum yield of GCDs was estimated to be 10.62%. Most importantly, this nanoparticle exhibited excellent optical stability.
To construct the GCDs-Ce6/Pt-EGF nanoplatform, researchers grafted chlorin e6 (Ce6), which is a photosensitizer, chemotherapy agent Pt (IV), and the targeting unit epidermal growth factor (EGF) on GCDs. Here, the drug loading rates of Ce6 and Pt (IV) were estimated to be 8.53% and 19.36%, respectively. The drug loading capacity of GCDs-Ce6/Pt-EGF nanoplatform was observed to be significantly more than other nanoplatforms.
Post irradiation at 660 nm wavelength, photosensitizer Ce6 induced cell death by generating reactive oxygen species (ROS). This phenomenon induced tumor cell apoptosis. Both in vitro and in vivo studies strongly indicated that the GCDs-Ce6/Pt-EGF exhibited superior photodynamic properties and could be effectively applied for esophageal tumor imaging as well as the elimination of esophageal cancer cells (therapeutic effect).
The mechanism driving the GCDs-Ce6/Pt-EGF nanoplatform is the targeting of esophageal cancer cells, bearing EGFR, and penetration of the tumor cells. After internalization within the tumor cells, Pt(IV) gets converted to Pt(II) by intracellular GSH, which ultimately kills tumor cells.
Interestingly, this study revealed that GCDs-Ce6/Pt-EGF displayed better anti-tumor effects compared to Cisplatin. Researchers stated that this nanomedicine could not only restrict tumor cell migration but also target tumor cells by recognizing EGF receptors. Other important aspects of this theranostic nanoplatform are direct cell killing capacity by Pt(II) and laser irradiation.
The GCDs-Ce6/Pt-EGF nanoplatform displayed excellent biosafety, as it rendered negligible cytotoxicity to normal esophageal cells. This could be due to three reasons, i.e., superior tumor targeting capability that reduces off-target toxicity, the release of toxic platinum only in GSH-rich tumor microenvironment, and Ce6 induced PDT effect with laser irradiation. Scientists are optimistic that utilizing all-in-one GCDs-Ce6/Pt-EGF theranostic nanoplatform could be beneficial for treating esophageal cancer patients.
News
The Brain’s Strange Way of Computing Could Explain Consciousness
Consciousness may emerge not from code, but from the way living brains physically compute. Discussions about consciousness often stall between two deeply rooted viewpoints. One is computational functionalism, which holds that cognition can be [...]
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
Cell Membranes May Act Like Tiny Power Generators
Living cells may generate electricity through the natural motion of their membranes. These fast electrical signals could play a role in how cells communicate and sense their surroundings. Scientists have proposed a new theoretical [...]
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
Nerve Damage Can Disrupt Immunity Across the Entire Body
A single nerve injury can quietly reshape the immune system across the entire body. Preclinical research from McGill University suggests that nerve injuries may lead to long-lasting changes in the immune system, and these [...]
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
